Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Pasteur MSD

This page shows the latest Sanofi Pasteur MSD news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

As part of Sanofi Pasteur, we expect our Flublok influenza vaccine to benefit from Sanofi Pasteur's expertise in the field of influenza vaccines.". ... their Sanofi Pasteur MSD joint venture.

Latest news

More from news
Approximately 3 fully matching, plus 50 partially matching documents found.

Latest Intelligence

  • Going fully digital Going fully digital

    Sanofi Pasteur MSD previously required upwards of nine months to bring approved commercial content to market in many of its largest markets. ... Sanofi Pasteur MSD also projects overall efficiency gains of 17% in year one and 33% annually in years two

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • STEM Healthcare bolsters its EU5 team STEM Healthcare bolsters its EU5 team

    Enrique Cruz-Jentoft (pictured right) has joined the agency as its general manager for Spain following pharmaceutical industry experience gained from servingand MSD. ... Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director

  • Dean Sowman joins Portland Health Dean Sowman joins Portland Health

    He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.

  • David Khougazian appointed president of Sanofi Pasteur MSD David Khougazian appointed president of Sanofi Pasteur MSD

    David Khougazian appointed president of Sanofi Pasteur MSD. He will succeed Dr Jean-Paul Kress atthe Sanofi Pasteur - Merck &Co venture. ... Olivier Charmeil, president and CEO of Sanofi Pasteur, said: “ Sanofi Pasteur MSD is a major player in the

  • Claire Hay joins UK creative agency Cherry Claire Hay joins UK creative agency Cherry

    In her new role at Cherry she joins the agency's senior management team and will have leadership responsibility for a number of clients, including Novo Nordisk and Sanofi Pasteur MSD.

  • emotive expands its team emotive expands its team

    He has been delivering pitches and proposals since starting at the agency and previously worked as a medical writer at Sanofi Pasteur MSD.

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Adam Goodband joins emotive as a Strategic Planner

    Adam Goodband joins emotive as a Strategic Planner. emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team. ... Having experienced working alongside emotive as a medical writer for Sanofi Pasteur MSD, Adam

  • emotive.

    emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team.

  • Publicis Resolute

    Boehringer Ingelheim. GSK. Janssen. Novartis. Pfizer. Sanofi. Sanofi Pasteur MSD. Shire.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics